Skip to content
10-Q

Quarterly Report

REGENXBIO Inc. RGNX

0001193125-25-174953

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 50.51M sh
Shares Diluted Q2 2025 · Jun 30, 2025 51.48M sh
Shares Diluted Q2 2025 · Jun 30, 2025 51.42M sh
Shares Diluted Q2 2025 · Jun 30, 2024 50.6M sh
Shares Diluted Q2 2025 · Jun 30, 2024 48.17M sh
Capex Q2 2025 · Jun 30, 2025 $1.42M
Capex Q2 2025 · Jun 30, 2024 $1.03M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$15.71M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$100.95M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $79.56M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $57.53M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $57.77M
Stockholders Equity Q2 2025 · Jun 30, 2025 $213.68M
Stockholders Equity Q2 2025 · Mar 31, 2025 $274.2M
Stockholders Equity Q2 2025 · Dec 31, 2024 $259.65M
Stockholders Equity Q2 2025 · Jun 30, 2024 $348.27M
Stockholders Equity Q2 2025 · Mar 31, 2024 $390.67M
Stockholders Equity Q2 2025 · Dec 31, 2023 $311.74M
Current Liabilities Q2 2025 · Jun 30, 2025 $119.54M
Current Liabilities Q2 2025 · Dec 31, 2024 $103.19M
Total Liabilities Q2 2025 · Jun 30, 2025 $367.35M
Total Liabilities Q2 2025 · Dec 31, 2024 $206.34M
Current Assets Q2 2025 · Jun 30, 2025 $373.75M
Current Assets Q2 2025 · Dec 31, 2024 $278M
Total Assets Q2 2025 · Jun 30, 2025 $581.03M
Total Assets Q2 2025 · Dec 31, 2024 $465.99M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.38
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.26
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.05
Eps Diluted Q2 2025 · Jun 30, 2024 −$2.41
Eps Basic Q2 2025 · Jun 30, 2025 −$1.38
Eps Basic Q2 2025 · Jun 30, 2025 −$1.26
Eps Basic Q2 2025 · Jun 30, 2024 −$1.05
Eps Basic Q2 2025 · Jun 30, 2024 −$2.41
Sga Expense Q2 2025 · Jun 30, 2025 $19.88M
Sga Expense Q2 2025 · Jun 30, 2025 $40.23M
Sga Expense Q2 2025 · Jun 30, 2024 $18.86M
Sga Expense Q2 2025 · Jun 30, 2024 $37.15M
Rd Expense Q2 2025 · Jun 30, 2025 $59.5M
Rd Expense Q2 2025 · Jun 30, 2025 $112.59M
Rd Expense Q2 2025 · Jun 30, 2024 $48.87M
Rd Expense Q2 2025 · Jun 30, 2024 $103.71M
Net Income Q2 2025 · Jun 30, 2025 −$70.87M
Net Income Q2 2025 · Jun 30, 2025 −$64.79M
Net Income Q2 2025 · Jun 30, 2024 −$52.99M
Net Income Q2 2025 · Jun 30, 2024 −$116.32M
Operating Income Q2 2025 · Jun 30, 2025 −$63.28M
Operating Income Q2 2025 · Jun 30, 2025 −$51.15M
Operating Income Q2 2025 · Jun 30, 2024 −$56.04M
Operating Income Q2 2025 · Jun 30, 2024 −$119.9M
Revenue Q2 2025 · Jun 30, 2025 $21.36M
Revenue Q2 2025 · Jun 30, 2025 $110.37M
Revenue Q2 2025 · Jun 30, 2024 $22.3M
Revenue Q2 2025 · Jun 30, 2024 $37.92M